Oncology

Macrophages
#Antibodies #Cancer research #Collaboration #Immuno-oncology #Japan #Macrophages #Oncology #Partnership #UK

Drug discovery partners from UK and Japan target macrophages

Macomics and Ono Pharmaceutical have entered a worldwide drug discovery collaboration agreement to develop new immuno-oncology antibody drugs against a novel macrophage target of interest in cancer. Under the terms of the agreement, Macomics will identify and characterise antibody candidates against the novel target of interest… Read More

#Cancer Research #News

#Breast cancer #Cancer research #CAR-T #Drug discovery #Immunotherapy #Oncology #Pancreatic cancer #Prostate cancer #Solid tumours

This week in drug discovery (20-24 March)

News round-up for 20-24 March by DDW Digital Content Editor Diana Spencer.  This week we have seen a number of developments in the treatment of solid tumours hitting the headlines. Pennsylvania researchers may have found a way to boost CAR-T therapy in these tumours, previously only successful in… Read More

#News

Cancer cell
#Breast cancer #Cancer research #Cancer treatment #Drug development #Drug discovery #Oncology

New global cancer research DDW eBook

This latest ebook sponsored by Sino Biological features insight on how the global drug discovery and development sector is making breakthroughs in cancer research.  Download this exclusive eBook to learn more about:  The global developments tackling the burden of cancer  … Read More

#News

Global cancer research eBook
#Breast cancer #Cancer research #Cancer treatment #Drug development #Drug discovery #Oncology

Global cancer research: Where are the breakthroughs?

This latest eBook sponsored by Sino Biological features insight on how the global drug discovery and development sector is making breakthroughs in cancer research.  Download this exclusive eBook to learn more about:  The global developments tackling the burden of cancer   Advances and challenges… Read More

#DDW eBooks #Intelligence

Monoclonal antibodies
#Biomarkers #Cancer research #Monoclonal antibodies #Oncology #Pancreatic cancer #Phase I trial

‘Encouraging’ data for monoclonal antibody in advanced cancers

Purple Biotech has revealed positive new results from exploratory analyses conducted as part of a Phase I dose escalation study into CM24 plus nivolumab for advanced cancer. The study enrolled 14 patients with advanced cancers including 11 patients with pancreatic adenocarcinoma (PDAC), two patients with colorectal… Read More

#Cancer Research #News

CAR-T therapy
#Cancer research #CAR-T #Cell therapy #CRISPR #CRISPR-Cas9 #Gene editing #Oncology #Solid tumours

Double knockout strategy could boost CAR-T in solid tumours

A new approach that delivers a ‘one-two punch’ to help T cells attack solid tumours is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania. The findings showed that targeting two regulators that control gene functions… Read More

#Cancer Research #News #Trending News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

Weekly drug discovery highlights podcast: Listen now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In the news this week, we have covered a number of early-stage studies that could… Read More

#News

Colorectal Cancer Awareness Month
#Cancer research #circular RNAs #Colorectal cancer #Immuno-oncology #Immunotherapy #Oncology

Colorectal Cancer Awareness Month: Drug discovery innovation

Diana Spencer explores the different ways the drug discovery sector is tackling colorectal cancer. Colorectal cancer is preventable with screening and often treatable when caught early, yet due to late diagnosis and chemotherapy resistance, it remains the second deadliest cancer in the United States. Read More

#Cancer Research #Exclusive Content

Doctor showing a model of the prostate
#Cancer research #Oncology #Phase III trial #Prostate cancer

Positive Phase III results for prostate cancer drug

Pfizer and Astellas have announced positive top-line results from the Phase III EMBARK trial evaluating XTANDI (enzalutamide) in men with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical recurrence (BCR). Patients enrolled in the trial were randomised to one of three study arms: XTANDI plus leuprolide,… Read More

#Cancer Research #News

#Drug development #Drug discovery #Oncology

New podcast on bringing new drugs to untreatable diseases

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this latest episode, DDW’s Megan Thomas is in conversation with Dr Simon Fricker, who… Read More

#News

Damaged DNA
#Biosensors #Cancer research #DNA #Korea #Oncology

Novel biosensor could help optimise cancer treatment

Scientists from Korea have developed a new biosensor that uses fluorescence resonance energy transfer (FRET) to detect DNA double-strand breaks in living specimens in real time. This biosensor has the potential to aid the development of new treatments for DNA damage-related diseases by revealing how our… Read More

#Cancer Research #News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

This week in drug discovery (13-17 March)

News round-up for 13-17 March by DDW Digital Content Editor Diana Spencer.  In the news this week we have covered a number of early-stage studies that could lead to potentially huge breakthroughs in the treatment of metastatic breast cancer, long Covid, bacterial diseases, bone cancer, and autoimmune… Read More

#News

Knee x-ray
#Cancer research #Cancer treatment #Genetics / genomics #Oncology #Preclinical investigations #University of East Anglia

Bone cancer drug increases survival rates by 50%

Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer. The study shows how a breakthrough drug called CADD522 blocks a gene associated with driving the cancer’s spread in mice implanted with… Read More

#Cancer Research #Editor's Choice #News

Cancer cell
#Breast cancer #Breast Cancer Now #Cancer research #Institute of Cancer Research #Oncology

New discovery could help prevent secondary breast cancer

Scientists have discovered why breast cancer cells that have spread to the lungs may ‘wake up’ following years of sleep – forming incurable secondary tumours. Patients with oestrogen receptor positive (ER+) breast cancer – the most common type – have a continued risk of their cancer… Read More

#Cancer Research #News #Trending News

#Cancer research #Clinical trial design #Clinical trials #Drug discovery #Gene therapy #Oncology

Podcast: Key stories from the drug discovery industry

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Perhaps most interestingly this week, after previous caution over in vivo… Read More

#News

#Cancer research #Clinical trial design #Clinical trials #Drug discovery #Gene therapy #Oncology

This week in drug discovery (6-10 March)

News round-up for 6-10 March by DDW Digital Content Editor Diana Spencer.  Perhaps most interestingly this week, after previous caution over in vivo gene therapy trials, the FDA has given the go ahead to Intellia Therapeutics to study NTLA-2002 in hereditary angioedema (HAE).  There have been several… Read More

#News